Project Number 2020EM_EM Agency/Funding Organization Cure Alzheimer's Fund Funding Year 2020 View Full Project Details for Reversal of Tau Pathology by an Adenosine A1 Receptor Antagonist Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Mandelkow, Eckhard, and Mandelkow, Eva-Maria Principal Investigator Mandelkow, Eckhard, and Mandelkow, Eva-Maria Awardee Organization DZNE Bonn Contact PI Country Germany Project Detail Funding Opportunity Announcement 2020 Research Grants FY Overall Cost $287,500 Funding Organization Agency/Funding Organization Cure Alzheimer's Fund Funding Organization Country United States Program Official CureAlzFund
